Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.

Ehman EC, Umetsu SE, Ohliger MA, Fidelman N, Ferrell LD, Yeh BM, Yee J, Hope TA.

Abdom Radiol (NY). 2016 Aug 3. [Epub ahead of print]

PMID:
27484789
2.

Proliferative Index Facilitates Distinction Between Benign Biliary Lesions and Intrahepatic Cholangiocarcinoma.

Tsokos CG, Krings G, Yilmaz F, Ferrell LD, Gill RM.

Hum Pathol. 2016 Jul 7. pii: S0046-8177(16)30139-3. doi: 10.1016/j.humpath.2016.06.019. [Epub ahead of print]

PMID:
27396933
3.

Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.

Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA.

Abdom Radiol (NY). 2016 May;41(5):963-9. doi: 10.1007/s00261-015-0623-5.

PMID:
27193793
4.

Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential.

Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, Liu TC, Makhlouf H, Marginean C, Nalbantoglu I, Sempoux C, Snover DC, Thung SN, Yeh MM, Ferrell LD.

Hum Pathol. 2016 Aug;54:143-151. doi: 10.1016/j.humpath.2016.03.018. Epub 2016 Apr 14.

PMID:
27090685
5.

Expression of liver fatty acid binding protein in hepatocellular carcinoma.

Cho SJ, Ferrell LD, Gill RM.

Hum Pathol. 2016 Apr;50:135-9. doi: 10.1016/j.humpath.2015.12.002. Epub 2015 Dec 18.

PMID:
26997447
6.

Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.

Stueck AE, Qu Z, Huang MA, Campreciós G, Ferrell LD, Thung SN.

Semin Liver Dis. 2015 Nov;35(4):444-9. doi: 10.1055/s-0035-1567827. Epub 2015 Dec 16.

PMID:
26676820
7.

Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.

Corey KE, Vuppalanchi R, Vos M, Kohli R, Molleston JP, Wilson L, Unalp-Arida A, Cummings OW, Lavine JE, Chalasani N; Nonalcoholic Steatohepatitis Clinical Research Network.

J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):360-7. doi: 10.1097/MPG.0000000000000584.

8.

Immunohistochemical pitfalls in the diagnosis of hepatocellular adenomas and focal nodular hyperplasia: accurate understanding of diverse staining patterns is essential for diagnosis and risk assessment.

Kakar S, Torbenson M, Jain D, Wu TT, Yeh M, Ferrell LD.

Mod Pathol. 2015 Jan;28(1):159-60. doi: 10.1038/modpathol.2014.121. No abstract available.

9.

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E; NASH Clinical Research Network.

Lancet. 2015 Mar 14;385(9972):956-65. doi: 10.1016/S0140-6736(14)61933-4. Epub 2014 Nov 7. Erratum in: Lancet. 2015 Mar 14;385(9972):946. Lancet. 2016 Apr 16;387(10028):1618.

10.

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N; NASH CRN.

Aliment Pharmacol Ther. 2015 Feb;41(3):301-9. doi: 10.1111/apt.13035. Epub 2014 Nov 28.

11.

Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease.

Schwimmer JB, Zepeda A, Newton KP, Xanthakos SA, Behling C, Hallinan EK, Donithan M, Tonascia J; Nonalcoholic Steatohepatitis Clinical Research Network.

PLoS One. 2014 Nov 24;9(11):e112569. doi: 10.1371/journal.pone.0112569. eCollection 2014.

12.

Monoclonal light chain deposits within the stomach manifesting as immunotactoid gastropathy.

Jen KY, Fix OK, Foster EN, Laszik ZG, Ferrell LD.

Ultrastruct Pathol. 2015 Feb;39(1):62-8. doi: 10.3109/01913123.2014.939796. Epub 2014 Sep 5.

PMID:
25191812
13.

Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Kakar S, Grenert JP, Paradis V, Pote N, Jakate S, Ferrell LD.

Mod Pathol. 2014 Nov;27(11):1499-509. doi: 10.1038/modpathol.2014.50. Epub 2014 Apr 18.

14.

Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category--reply.

Kakar S, Evason KJ, Ferrell LD.

Hum Pathol. 2014 Mar;45(3):660-1. doi: 10.1016/j.humpath.2013.09.019. Epub 2013 Nov 21. No abstract available.

PMID:
24529332
15.

Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.

Molleston JP, Schwimmer JB, Yates KP, Murray KF, Cummings OW, Lavine JE, Brunt EM, Scheimann AO, Unalp-Arida A; NASH Clinical Research Network.

J Pediatr. 2014 Apr;164(4):707-713.e3. doi: 10.1016/j.jpeds.2013.10.071. Epub 2013 Dec 19.

16.

Different collagen types show distinct rates of increase from early to late stages of hepatitis C-related liver fibrosis.

Chen W, Rock JB, Yearsley MM, Ferrell LD, Frankel WL.

Hum Pathol. 2014 Jan;45(1):160-5. doi: 10.1016/j.humpath.2013.08.015.

PMID:
24321525
17.

Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.

Joseph NM, Ferrell LD, Jain D, Torbenson MS, Wu TT, Yeh MM, Kakar S.

Mod Pathol. 2014 Jan;27(1):62-72. doi: 10.1038/modpathol.2013.114. Epub 2013 Jun 28.

18.

Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.

Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J; Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN).

Aliment Pharmacol Ther. 2013 Jul;38(2):134-43. doi: 10.1111/apt.12352. Epub 2013 May 29.

19.

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R; NASH CRN.

Hepatology. 2013 Nov;58(5):1644-54. doi: 10.1002/hep.26465. Epub 2013 Oct 2.

20.

Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.

Evason KJ, Grenert JP, Ferrell LD, Kakar S.

Hum Pathol. 2013 May;44(5):750-8. doi: 10.1016/j.humpath.2012.07.019. Epub 2012 Oct 16.

PMID:
23084586
Items per page

Supplemental Content

Loading ...
Write to the Help Desk